Nls Pharmaceutics Ag Stock News

NLS Pharmaceutics Ltd (NASDAQ: NLSP) has announced interim topline data from its Phase 2a trial of its lead product candidate, Quilience (Mazindol ER), in narcolepsy.  For excessive daytime sleepi

Penny stocks for your watch list this month. The post 3 Penny Stocks To Watch For Your List In March 2022 appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

NLS Pharmaceutics Ltd NLSP shares are trading higher after the Company announced to present interim topline data from its Phase 2a trial evaluating its lead product candidate, Quilience (Mazindol ER)

Phase 2a trial meets enrollment target for interim analysis and is now more than 50% enrolled 21 clinical sites in the United States actively enrolling patients Nearly 90% of patients completing the t

NLS Pharmaceutics Ltd (NLSP) shares closed today at 1.9% above its 52 week low of $1.07, giving the company a market cap of $16M. The stock is currently down 1.8% year-to-date, down 62.3% over the past 12 months, and down 62.3% over the past five years. This week, the Dow Jones Industrial Average fell 0.9%, and the S&P 500 fell 0.3%. Trading Activity Trading volume this week was 94.4% lower than the 20-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 0.0. Technical Indicators The Relative Strength Index (RSI) on the stock was between 30 and 70.MACD, a trend-following momentum indicator, indicates a downward trend.The stock closed above its Bollinger band, indicating it may be overbought. Market Comparative Performance The company's share price is the same as the S&P 500 Index , lags it on a 1-year basis, and lags it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , lags it on a 1-year basis, and lags it on a 5-year basis Per Group Comparative Performance The company's stock price performance year-to-date lags the peer average by 47.2% The company's stock price performance over the past 12 months lags the peer average by 627.6% This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to [email protected]. © 2020 Kwhen Inc.

NLS Pharmaceutics Ltd (NLSP) shares closed today at 1.9% above its 52 week low of $1.07, giving the company a market cap of $16M. The stock is currently down 1.8% year-to-date, down 62.3% over the past 12 months, and down 62.3% over the past five years. This week, the Dow Jones Industrial Average fell 0.3%, and the S&P 500 fell 0.7%. Trading Activity Trading volume this week was 94.4% lower than the 20-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 0.0. Technical Indicators The Relative Strength Index (RSI) on the stock was between 30 and 70.MACD, a trend-following momentum indicator, indicates a downward trend.The stock closed above its Bollinger band, indicating it may be overbought.The stock closed at 4.4% lower than its 5-day moving average, 12.3% lower than its 20-day moving average, and 44.4% lower than its 90-day moving average. Market Comparative Performance The company's share price is the same as the S&P 500 Index , lags it on a 1-year basis, and lags it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , lags it on a 1-year basis, and lags it on a 5-year basis Per Group Comparative Performance The company's stock price performance year-to-date lags the peer average by 354.8% The company's stock price performance over the past 12 months lags the peer average by 628.6% This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to [email protected]. © 2020 Kwhen Inc.

NLS Pharmaceutics Ltd (NLSP) shares closed today at 0.9% above its 52 week low of $1.10, giving the company a market cap of $17M. The stock is currently up 6.3% year-to-date, down 59.2% over the past 12 months, and down 59.2% over the past five years. This week, the Dow Jones Industrial Average fell 0.3%, and the S&P 500 rose 0.6%. Trading Activity Trading volume this week was 82.7% lower than the 20-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 0.0. Technical Indicators The Relative Strength Index (RSI) on the stock was between 30 and 70.MACD, a trend-following momentum indicator, indicates a downward trend.The stock closed above its Bollinger band, indicating it may be overbought. Market Comparative Performance The company's share price is the same as the S&P 500 Index , lags it on a 1-year basis, and lags it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , lags it on a 1-year basis, and lags it on a 5-year basis Per Group Comparative Performance The company's stock price performance year-to-date beats the peer average by -1005.3% The company's stock price performance over the past 12 months lags the peer average by 591.2% This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to [email protected]. © 2020 Kwhen Inc.

Here are three penny stocks to add to your watchlist for next week The post 3 Penny Stocks to Watch in the Second Week of January appeared first on Penny Stocks to Buy, Picks, News and Information | P

Here are three penny stocks to add to your watchlist for next week The post 3 Penny Stocks to Watch in the Second Week of January appeared first on Penny Stocks to Buy, Picks, News and Information | P

NLS Pharmaceutics Ltd (NLSP) shares closed today 15.8% lower than it did at the end of yesterday. The stock is currently up 36.9% year-to-date, down 47.4% over the past 12 months, and down 47.4% over the past five years. Today, the Dow Jones Industrial Average fell 0.5%, and the S&P 500 fell 0.1%. Trading Activity Shares traded as high as $2.40 and as low as $1.10 this week.Shares closed 82.6% below its 52-week high and 16.4% above its 52-week low.Trading volume this week was 74.7% lower than the 10-day average and 29.3% lower than the 30-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 0.0. Technical Indicators The Relative Strength Index (RSI) on the stock was between 30 and 70.MACD, a trend-following momentum indicator, indicates a downward trend.The stock closed above its Bollinger band, indicating it may be overbought. Market Comparative Performance The company's share price lags the S&P 500 Index today, lags it on a 1-year basis, and lags it on a 5-year basis The company's share price lags the Dow Jones Industrial Average today, lags it on a 1-year basis, and lags it on a 5-year basis Per Group Comparative Performance The company's stock price performance year-to-date beats the peer average by 5056.7% The company's stock price performance over the past 12 months lags the peer average by 515.9% This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to [email protected]. © 2020 Kwhen Inc.

The stock price of NLS Pharmaceutics AG (NASDAQ: NLSP) increased by over 80% during intraday trading today. This is why it happened.

STANS, SWITZERLAND / ACCESSWIRE / October 14, 2021 / NLS Pharmaceutics Ltd. (NASDAQ:NLSP, NLSPW) ("NLS" or the "Company"), a Swiss clinical-stage biopharmaceutical company focused on the discovery and

STANS, SWITZERLAND / ACCESSWIRE / September 30, 2021 / NLS Pharmaceutics Ltd. (Nasdaq:NLSP, NLSPW) ("NLS" or the "Company"), a Swiss clinical-stage pharmaceutical company focused on the discovery and

The shares of NLS Pharmaceutics Ltd. (NASDAQ:NLSP) increased by over 30% intraday.

Looking to buy penny stocks in 2021? Check these 3 out for your list The post Buying Penny Stocks Right Now?